GUARDANT Financial Statements From 2010 to 2024

5GH Stock  EUR 32.61  1.02  3.03%   
GUARDANT HEALTH financial statements provide useful quarterly and yearly information to potential GUARDANT HEALTH CL investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on GUARDANT HEALTH financial statements helps investors assess GUARDANT HEALTH's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting GUARDANT HEALTH's valuation are summarized below:
GUARDANT HEALTH CL does not today have any fundamental measures for analysis.
Check GUARDANT HEALTH financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GUARDANT HEALTH's main balance sheet or income statement drivers, such as , as well as many indicators such as . GUARDANT financial statements analysis is a perfect complement when working with GUARDANT HEALTH Valuation or Volatility modules.
  
This module can also supplement various GUARDANT HEALTH Technical models . Check out the analysis of GUARDANT HEALTH Correlation against competitors.
For more detail on how to invest in GUARDANT Stock please use our How to Invest in GUARDANT HEALTH guide.

GUARDANT HEALTH CL Company Shares Outstanding Analysis

GUARDANT HEALTH's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current GUARDANT HEALTH Shares Outstanding

    
  102.44 M  
Most of GUARDANT HEALTH's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GUARDANT HEALTH CL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, GUARDANT HEALTH CL has 102.44 M of shares currently outstending. This is 43.26% lower than that of the Healthcare sector and 28.22% lower than that of the Diagnostics & Research industry. The shares outstanding for all Germany stocks is 82.09% higher than that of the company.

GUARDANT HEALTH CL Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GUARDANT HEALTH's current stock value. Our valuation model uses many indicators to compare GUARDANT HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GUARDANT HEALTH competition to find correlations between indicators driving GUARDANT HEALTH's intrinsic value. More Info.
GUARDANT HEALTH CL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GUARDANT HEALTH's earnings, one of the primary drivers of an investment's value.

About GUARDANT HEALTH Financial Statements

GUARDANT HEALTH stakeholders use historical fundamental indicators, such as GUARDANT HEALTH's revenue or net income, to determine how well the company is positioned to perform in the future. Although GUARDANT HEALTH investors may analyze each financial statement separately, they are all interrelated. For example, changes in GUARDANT HEALTH's assets and liabilities are reflected in the revenues and expenses on GUARDANT HEALTH's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GUARDANT HEALTH CL. Please read more on our technical analysis and fundamental analysis pages.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. GUARDANT HEALTH operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 864 people.

Currently Active Assets on Macroaxis

Other Information on Investing in GUARDANT Stock

GUARDANT HEALTH financial ratios help investors to determine whether GUARDANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GUARDANT with respect to the benefits of owning GUARDANT HEALTH security.